BIOTRONIK SE & Co. KG Sustainability Profile
BIOTRONIK SE & Co. KG, a leading global medical technology company, is headquartered in Berlin, Germany. Founded in 1963, BIOTRONIK has established itself as a pioneer in the cardiovascular and endovascular sectors, focusing on innovative solutions for cardiac rhythm management, vascular intervention, and electrophysiology. With a strong presence in Europe, North America, and Asia, the company is renowned for its advanced implantable devices and cutting-edge technologies, such as its bioresorbable stents and remote monitoring systems. BIOTRONIK's commitment to quality and innovation has earned it a prominent position in the medical device industry, marked by numerous accolades and a reputation for excellence in patient care.
DitchCarbon Score
How does BIOTRONIK SE & Co. KG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOTRONIK SE & Co. KG's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOTRONIK SE & Co. KG's reported carbon emissions
BIOTRONIK SE & Co. KG, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that BIOTRONIK may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As a result, it is unclear how BIOTRONIK is addressing climate change or its carbon emissions, which is increasingly important in the medical technology sector. The absence of emissions data and reduction initiatives may reflect a broader trend within the industry, where companies are under pressure to enhance transparency and accountability regarding their environmental impact.
How Carbon Intensive is BIOTRONIK SE & Co. KG's Industry?
How Carbon Intensive is BIOTRONIK SE & Co. KG's Location?
BIOTRONIK SE & Co. KG's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
BIOTRONIK SE & Co. KG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Neuspera Medical Inc.
Stimwave LLC
InspireMD, Inc.
Smith Plus Nephew
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.